Patients who may benefit most include: Adults with type 2 diabetes and hypertension This represents a common clinical scenario where metabolic and cardiovascular risk factors coexist
Wegovy (semaglutide) : Similar to Ozempic but at a higher dose, approved specifically for weight management
2020 May;57(5):583-587 Qiu S, Cai X, Wu T , Sun Z, Guo H, Kirsten J, Wendt J, Steinacker JM, and Schumann U
Mahir Yousif is a leading aesthetic specialist with over 15 years of experience in non-invasive skin treatments
It is worth noting that, consistent with experience across the GLP-1/GIP class, weight loss in people with type 2 diabetes may be somewhat smaller in magnitude compared with those with obesity alone